Zobrazeno 1 - 10
of 4 284
pro vyhledávání: '"REMITTING MULTIPLE-SCLEROSIS"'
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 5985-5996 (2024)
Zeinab Awada,1 Natasha Hameed,2 Asaff Harel1,2 1Northwell Comprehensive Multiple Sclerosis Center, Department of Neurology, Lenox Hill Hospital/Donald and Barbara Zucker School of Medicine at Hofstra, New York, NY, USA; 2Northwell Comprehensive Multi
Externí odkaz:
https://doaj.org/article/f4f095d4b34142fbb18de24a7d9e89e8
Autor:
Saskia Räuber, Andreas Schulte-Mecklenbeck, Alice Willison, Ramona Hagler, Marius Jonas, Duygu Pul, Lars Masanneck, Christina B. Schroeter, Kristin S. Golombeck, Stefanie Lichtenberg, Christine Strippel, Marco Gallus, Andre Dik, Ruth Kerkhoff, Sumanta Barman, Katharina J. Weber, Stjepana Kovac, Melanie Korsen, Marc Pawlitzki, Norbert Goebels, Tobias Ruck, Catharina C. Gross, Werner Paulus, Guido Reifenberger, Michael Hanke, Oliver Grauer, Marion Rapp, Michael Sabel, Heinz Wiendl, Sven G. Meuth, Nico Melzer
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-21 (2024)
Abstract Background Immune dysregulation is a hallmark of autoimmune diseases of the central nervous system (CNS), characterized by an excessive immune response, and primary CNS tumors (pCNS-tumors) showing a highly immunosuppressive parenchymal micr
Externí odkaz:
https://doaj.org/article/848c9d49598a4962b05d92211b97ff55
Publikováno v:
Neurology and Therapy, Vol 13, Iss 6, Pp 1597-1605 (2024)
Abstract In clinical trials, the percentage of patients discontinuing treatment with ocrelizumab due to adverse events was low. However, real-world populations are often more diverse than randomized controlled trials (RCTs), therefore it is important
Externí odkaz:
https://doaj.org/article/67eff6a1035949529fbd59a77ece58b4
Autor:
Foziah Jabbar Gossab Alshamrani, Azra Zafar, Rahmah Majed Alsawad, Zakia Yasawy, Rizwana Shahid, Saima Nazish, Erum Shariff, Nehad Mahmoud Soltan
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 12, Iss 4, Pp 299-305 (2024)
Background There is scant data regarding the use of oral disease-modifying treatments (oDMT) in patients with relapsing–remitting multiple sclerosis (PwRRMS) from Saudi Arabia. Objective This study aimed to identify the response rate to oDMT in PwR
Externí odkaz:
https://doaj.org/article/f980ab3b87674ea686083256dab0d6f8
Publikováno v:
Medičnì Perspektivi, Vol 29, Iss 3, Pp 137-143 (2024)
Multiple sclerosis is a chronic autoimmune inflammatory disease that affects the brain and spinal cord. The most common form of this disease according to the type of its course is relapsing-remitting multiple sclerosis. Comorbidity in multiple sclero
Externí odkaz:
https://doaj.org/article/673a27ca41644f3fa7e4c8fe26384b15
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 25-30 (2024)
SinnoVex is a drug from the group of bioanalogues of interferon beta-1a for intramuscular administration, which has moderate efficacy in reducing clinical exacerbations of multiple sclerosis (MS), which is most pronounced in the initial treatment of
Externí odkaz:
https://doaj.org/article/b4011af1684c4e979fbc195b3851e545
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 32, Iss 3, Pp 245-254 (2024)
Multiple sclerosis (MS) is a debilitating neurological disease characterized by inflammation, demyelination, and neurodegeneration in the central nervous system. Despite extensive research, the pathology of MS remains incompletely understood. Ocreliz
Externí odkaz:
https://doaj.org/article/5ca210c4947f4e94882b1ceb14d459a7
Publikováno v:
Brain and Behavior, Vol 14, Iss 10, Pp n/a-n/a (2024)
ABSTRACT Background/Objectives This systematic review and meta‐analysis aimed to investigate the role of magnetic susceptibility (χ) in deep gray matter (DGM) structures, including the putamen (PUT), globus pallidus (GP), caudate nucleus (CN), and
Externí odkaz:
https://doaj.org/article/3f8374ddfce04760a05f0ab63d5e1fb3
Evaluation relationship between VDR gene and clinical and inflammatory factors in patients with RRMS
Autor:
Maryam Milanifard, Soraya Mehrabi, Reza Ahadi, Mohsen Nabiuni, Samaneh Azimi Souteh, Mohammad Taghi Joghataei
Publikováno v:
European Journal of Translational Myology (2024)
Introduction: Adipocyte levels including leptin and FABS-4 levels, adiponectin, obesity, and vitamin D can be related to the occurrence and exacerbation of MS disease. Objective: This research aimed at determining the relationship between VDR gene
Externí odkaz:
https://doaj.org/article/f02ab225f19d4e169dbb170246c0c59e
Autor:
Esther Ganelin‐Cohen, Chen Buxbaum, Noam Bosak, Shani Sobol, Adi Vaknin‐Dembinsky, Mark A Hellmann, Adi Wilf‐Yarkoni, Keren Regev, Elizaveta Pustovoyt, Alla Shifrin, Yair Wexler, Ayal Rozenberg
Publikováno v:
Brain and Behavior, Vol 14, Iss 7, Pp n/a-n/a (2024)
Abstract Introduction Examining the safety of theBNT162b2 mRNA vaccine in multiple sclerosis (MS) patients remains inconclusive, particularly regarding the potential for disease exacerbations. This study aims to assess the effects of BNT162b2 COVID
Externí odkaz:
https://doaj.org/article/83f6312cb48b48198f138f5ff81dad63